Israel’s Pharma Two B (see here previously) is presenting the full results of its Phase 3 trial of its once-a-day injection of its P2B001 treatment for Parkinson’s disease. P2B001 combines low-dose pramipexole with low-dose rasagiline. It relieves PD symptoms with … Continue reading →

Sheba Medical Center has deployed a new accelerated, AI-powered cancer diagnostics research platform to improve patient diagnosis, treatment, and outcomes. It utilizes solutions of various Israeli startups, including that of Imagene (see here previously). https://www.israelnationalnews.com/news/375264

Healthcare app Together by Renee is integrating the video-based biomarker check technology from Israel’s Binah.ai (see here previously). The platform allows US seniors to easily check and share vital signs with caregivers and family, using their smartphone cameras. https://www.prweb.com/releases/2023/07/prweb19458579.htm

Joint Israeli & US research has revealed crucial insights into the early development of specialized tissues that protect the fetus during human pregnancy. The findings can potentially help prevent dangerous pregnancy complications, like pre-eclampsia and preterm birth. https://www.timesofisrael.com/new-technology-enables-researchers-to-better-understand-early-placental-development/ https://www.nature.com/articles/s41586-023-06298-9

Israel’s Sofwave Medical (see here previously) has received US FDA approval for its treatment for acne scars. 88% of patients reported an improvement in a clinical study of Sofwave’s Synchronous Ultrasound Parallel Beam (SUPERB) technology. https://nocamels.com/2023/08/fda-okays-israel-developed-treatment-for-acne-scars/

Israel’s Neurosteer (see here previously) has developed a musical test for the early detection of Parkinson’s Disease as well as Alzheimer’s and other forms of dementia.  Patients conduct a series of musical tasks while sensors connected to an EEG device … Continue reading →